+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-Invasive Prenatal DNA Testing Service Market by Application, Technology, End User, Distribution Channel, Service Model, Sample Type - Global Forecast 2025-2030- Product Image
Non-Invasive Prenatal DNA Testing Service Market by Application, Technology, End User, Distribution Channel, Service Model, Sample Type - Global Forecast 2025-2030- Product Image
New

Non-Invasive Prenatal DNA Testing Service Market by Application, Technology, End User, Distribution Channel, Service Model, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140264
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Non-invasive prenatal DNA testing has rapidly ascended to a central role in maternal-fetal healthcare by offering early and reliable detection of chromosomal anomalies without the risks associated with invasive procedures. Leveraging cell-free fetal DNA circulating in maternal blood the service enables detection of genetic conditions with remarkable accuracy. As clinical guidelines evolve and awareness grows among expectant parents healthcare providers are integrating these tests into standard prenatal care pathways, reflecting a transformative shift in patient management.

This executive summary distills the key drivers regulatory influences and technological advancements shaping the non-invasive prenatal DNA testing landscape. It examines pivotal shifts in clinical adoption emerging tariff impacts on supply chains detailed market segmentation insights regional variations competitive dynamics and actionable recommendations for stakeholders. The goal is to provide decision-makers with a concise yet thorough overview of the factors that will define the trajectory of the prenatal testing market in the coming years.

Unveiling the Disruptive Forces Driving a Paradigm Shift in the Non Invasive Prenatal DNA Testing Landscape and Emerging Clinical Practices

The landscape of non-invasive prenatal DNA testing is undergoing a fundamental transformation as novel sequencing methodologies and digital molecular techniques converge to elevate diagnostic precision. Next-generation sequencing platforms coupled with targeted single-nucleotide polymorphism analyses have enhanced the detection spectrum beyond common aneuploidies to include rare microdeletions and sex chromosome anomalies. Concurrently digital polymerase chain reaction innovations such as droplet partitions and BEAMing are delivering rapid turnaround times that facilitate timely clinical decision making.

Moreover regulatory bodies worldwide are issuing new guidance frameworks and expanding coverage policies, prompting laboratories to adopt standardized protocols and quality benchmarks. Integration of telehealth consultations alongside remote sample collection is extending reach into underserved regions and fostering patient engagement. With ongoing advancements in microarray technologies and improvements in bioinformatic interpretation the service model is shifting from a purely diagnostic tool to a comprehensive prenatal risk assessment resource, reshaping physician workflows and elevating patient expectations.

Assessing the Ripple Effects of Newly Imposed United States Tariffs on Prenatal DNA Testing Components and Supply Chain Dynamics

The introduction of cumulative tariffs on key laboratory reagents and sequencing instruments by the United States has created immediate challenges for providers of non-invasive prenatal DNA testing. Import duties imposed on imported polymerase chain reaction kits and microarray substrates have increased per-test costs, prompting diagnostic laboratories to reassess reagent inventories and evaluate alternative suppliers. These cost pressures have the potential to slow adoption rates among price-sensitive clinics and could necessitate renegotiation of reimbursement rates with payers to sustain viability.

In response, leading laboratories are diversifying their sourcing strategies by exploring regional manufacturing partnerships and investing in domestic production of consumables. Collaborative initiatives between equipment manufacturers and academic centers aim to streamline supply chains and reduce exposure to tariff escalations. Over time trade negotiations and potential exemptions for critical healthcare technologies may alleviate some of these burdens, but in the interim stakeholders must navigate a more complex procurement environment while preserving test affordability and accessibility for expectant families.

Delving into Key Segment Dynamics Revealing How Diverse Application Categories and Technological Platforms Shape Testing Service Offerings

A nuanced analysis of market segmentation reveals how distinct application categories drive specialized testing workflows and service portfolios. Within the spectrum of microdeletion syndromes the focus on conditions such as 1p36 deletion and 22q11 deletion has expanded, while sex chromosome assessments increasingly target Klinefelter and Turner syndromes. Meanwhile trisomy detection persists as the most established category with Down syndrome Edwards syndrome and Patau syndrome serving as primary diagnostic targets.

From a technological standpoint the market is structured around digital polymerase chain reaction approaches, encompassing droplet digital and BEAMing platforms, alongside microarray methodologies such as array comparative genomic hybridization and SNP microarrays. Next-generation sequencing remains the most versatile option, with targeted panels SNP sequencing and whole-genome analyses each offering varying depths of insight. End users span clinics offering point-of-care services to specialized diagnostic laboratories and hospital-based testing units, reflecting a tiered adoption model.

Distribution channels include direct-to-consumer pathways facilitated by online ordering and retail pharmacy kits as well as established healthcare provider networks within hospitals and obstetrics clinics. Service models range from centralized reference lab operations administered by contract or academic facilities to decentralized setups in clinic-based and hospital laboratories. Finally sample typologies have evolved from invasive specimens to alternatives such as dried blood spots, maternal plasma, and even urine extracts, broadening accessibility and patient convenience.

Mapping Regional Trends Across Americas Europe Middle East and Africa and Asia Pacific to Illuminate Growth Opportunities and Healthcare Infrastructure

Regional analysis underscores divergent growth trajectories influenced by healthcare infrastructure, regulatory frameworks, and demographic trends. In the Americas, robust reimbursement mechanisms and a high concentration of specialized diagnostic laboratories have accelerated the adoption of non-invasive testing, while ongoing collaborations between payers and providers are refining coverage policies to support broader access.

Across Europe Middle East and Africa a mosaic of regulatory requirements and economic conditions has created opportunities for tailored service models. Leading economies in Western Europe are advancing standardized protocols and cross-border testing initiatives, whereas emerging markets in the Middle East and North Africa are benefiting from strategic public-private partnerships aimed at enhancing maternal health outcomes.

In Asia-Pacific rapid urbanization and expanding prenatal care programs are driving increased demand for early genetic screening. Market entrants in developed East Asian countries are leveraging advanced sequencing infrastructure, while Southeast Asian and Oceanian regions are exploring decentralized laboratory networks and telehealth-driven sample collection to overcome geographical barriers.

Examining Strategic Moves and Collaborative Ventures of Leading Industry Players Strengthening the Competitive Footprint in Prenatal Testing

Leading providers in the non-invasive prenatal DNA testing domain are forging strategic alliances to bolster their technological and geographical footprints. Collaborative research agreements between sequencing platform vendors and clinical laboratories have enabled co-development of targeted panels for rare genetic conditions. Simultaneously diagnostic kit manufacturers have secured licensing deals with academic genomics centers to expand assay portfolios and enhance analytical sensitivity.

Partnerships between data analytics firms and healthcare networks are delivering enriched interpretation services that streamline workflow integration for obstetric practitioners. In parallel several global diagnostic companies have pursued acquisition strategies to consolidate laboratory networks and standardize testing procedures across multiple regions. These combined efforts are intensifying competitive dynamics and elevating the bar for test performance, service turnaround, and comprehensive support offerings.

Formulating Actionable Strategies for Industry Leaders to Navigate Regulatory Complexities and Capitalize on Technological Innovations in Prenatal Testing

Industry leaders should prioritize investment in scalable sequencing technologies and automation to reduce per-sample processing time and enhance throughput. Diversifying supply chains through regional manufacturing partnerships will mitigate exposure to tariff fluctuations and ensure consistent reagent availability. Engaging proactively with payer organizations to develop value-based reimbursement models can foster sustainable pricing structures that align service costs with clinical outcomes.

Strengthening alliances with obstetric care networks and genetic counseling services will drive deeper clinical integration and support broad patient education initiatives. Expanding decentralized laboratory capabilities in key emerging markets and leveraging telehealth platforms will extend reach into previously underserved areas. Finally incorporating advanced bioinformatics and machine learning tools into test interpretation workflows will differentiate service offerings and deliver actionable insights for clinicians and patients alike.

Outlining a Rigorous Research Methodology Integrating Qualitative Insights and Quantitative Data to Ensure Comprehensive Market Intelligence

This analysis is grounded in a rigorous mixed-methods approach that synthesizes qualitative insights from interviews with key opinion leaders, laboratory directors, and regulatory experts with quantitative data gathered from peer-reviewed publications and public health databases. Primary research included in-depth discussions to validate emerging trends in technology adoption and reimbursement practices, while secondary research sourced regulatory filings clinical guidelines and supply chain documentation.

Data triangulation methods were employed to cross-verify information from multiple independent sources and ensure robustness of key findings. An expert advisory panel provided structured feedback on draft interpretations to align the narrative with real-world operational challenges. All assumptions and methodologies have been documented transparently to facilitate reproducibility and support stakeholders in applying findings to their strategic planning.

Concluding Synthesis Emphasizing Critical Insights on Market Evolution Clinical Adoption and Pathways to Enhanced Patient Outcomes

In conclusion, the non-invasive prenatal DNA testing sector stands at a pivotal juncture where technological progress, regulatory evolution, and shifting reimbursement landscapes converge. The detailed segmentation analysis highlights opportunities across microdeletion, chromosome, and trisomy diagnostics, while technological platforms from digital PCR to whole-genome sequencing offer distinct value propositions. Regional disparities underscore the necessity for adaptable service models that align with local infrastructure and payer environments.

Competitive dynamics are intensifying as major players forge collaborations and pursue strategic acquisitions to enhance assay capabilities and expand market reach. Stakeholders who embrace diversified sourcing strategies proactive payer engagement and targeted regional expansion will be best positioned to drive adoption and deliver improved patient outcomes. The actionable recommendations provided herein serve as a roadmap for navigating current challenges and capitalizing on the growth potential within prenatal testing.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Microdeletion Syndrome
      • 1p36 Deletion Syndrome
      • 22q11 Deletion Syndrome
    • Sex Chromosome Abnormality
      • Klinefelter Syndrome
      • Turner Syndrome
    • Trisomy Detection
      • Down Syndrome
      • Edwards Syndrome
      • Patau Syndrome
  • Technology
    • Digital PCR
      • BEAMing
      • Droplet Digital PCR
    • Microarray
      • Array Comparative Genomic Hybridization
      • SNP Microarray
    • Next-Generation Sequencing
      • Single-Nucleotide Polymorphism Sequencing
      • Targeted Sequencing
      • Whole-Genome Sequencing
  • End User
    • Clinics
    • Diagnostic Laboratories
    • Hospitals
  • Distribution Channel
    • Direct-to-Consumer
      • Online Platforms
      • Retail Pharmacies
    • Healthcare Providers
      • Hospitals
      • Obstetrics Clinics
  • Service Model
    • Centralized
      • Contract Laboratories
      • Reference Laboratories
    • Decentralized
      • Clinic-Based Laboratories
      • Hospital Laboratories
  • Sample Type
    • Dried Blood Spot
    • Maternal Plasma
    • Urine
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Natera, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • BGI Genomics Co., Ltd.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Myriad Genetics, Inc.
  • Invitae Corporation
  • PerkinElmer, Inc.
  • Progenity, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of expanded cell-free DNA screening panels to include microdeletion and monogenic disorder detection
5.2. Integration of artificial intelligence and machine learning algorithms to reduce cfDNA test turnaround times and improve specificity
5.3. Growing partnerships between prenatal care providers and genetic counseling platforms to streamline noninvasive testing workflows
5.4. Emergence of at-home prenatal DNA collection kits increasing patient convenience and direct-to-patient testing accessibility
5.5. Implementation of universal first-trimester cfDNA screening programs aimed at reducing invasive diagnostic procedures across healthcare systems
5.6. Rising focus on multiethnic reference genome libraries to enhance noninvasive prenatal test accuracy in diverse populations
5.7. Regulatory expansions and reimbursement policy updates driving wider coverage of noninvasive prenatal DNA tests among private insurers
5.8. Advancements in high-throughput sequencing technologies lowering cost per test and accelerating market penetration globally
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Non-Invasive Prenatal DNA Testing Service Market, by Application
8.1. Introduction
8.2. Microdeletion Syndrome
8.2.1. 1p36 Deletion Syndrome
8.2.2. 22q11 Deletion Syndrome
8.3. Sex Chromosome Abnormality
8.3.1. Klinefelter Syndrome
8.3.2. Turner Syndrome
8.4. Trisomy Detection
8.4.1. Down Syndrome
8.4.2. Edwards Syndrome
8.4.3. Patau Syndrome
9. Non-Invasive Prenatal DNA Testing Service Market, by Technology
9.1. Introduction
9.2. Digital PCR
9.2.1. BEAMing
9.2.2. Droplet Digital PCR
9.3. Microarray
9.3.1. Array Comparative Genomic Hybridization
9.3.2. SNP Microarray
9.4. Next-Generation Sequencing
9.4.1. Single-Nucleotide Polymorphism Sequencing
9.4.2. Targeted Sequencing
9.4.3. Whole-Genome Sequencing
10. Non-Invasive Prenatal DNA Testing Service Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Diagnostic Laboratories
10.4. Hospitals
11. Non-Invasive Prenatal DNA Testing Service Market, by Distribution Channel
11.1. Introduction
11.2. Direct-to-Consumer
11.2.1. Online Platforms
11.2.2. Retail Pharmacies
11.3. Healthcare Providers
11.3.1. Hospitals
11.3.2. Obstetrics Clinics
12. Non-Invasive Prenatal DNA Testing Service Market, by Service Model
12.1. Introduction
12.2. Centralized
12.2.1. Contract Laboratories
12.2.2. Reference Laboratories
12.3. Decentralized
12.3.1. Clinic-Based Laboratories
12.3.2. Hospital Laboratories
13. Non-Invasive Prenatal DNA Testing Service Market, by Sample Type
13.1. Introduction
13.2. Dried Blood Spot
13.3. Maternal Plasma
13.4. Urine
14. Americas Non-Invasive Prenatal DNA Testing Service Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Non-Invasive Prenatal DNA Testing Service Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Non-Invasive Prenatal DNA Testing Service Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Natera, Inc.
17.3.2. F. Hoffmann-La Roche Ltd.
17.3.3. Illumina, Inc.
17.3.4. BGI Genomics Co., Ltd.
17.3.5. Laboratory Corporation of America Holdings
17.3.6. Quest Diagnostics Incorporated
17.3.7. Myriad Genetics, Inc.
17.3.8. Invitae Corporation
17.3.9. PerkinElmer, Inc.
17.3.10. Progenity, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET: RESEARCHAI
FIGURE 28. NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET: RESEARCHSTATISTICS
FIGURE 29. NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET: RESEARCHCONTACTS
FIGURE 30. NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY 1P36 DELETION SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY 1P36 DELETION SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY 22Q11 DELETION SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY 22Q11 DELETION SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY KLINEFELTER SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY KLINEFELTER SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TURNER SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TURNER SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DOWN SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DOWN SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY EDWARDS SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY EDWARDS SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY PATAU SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY PATAU SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY BEAMING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY BEAMING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY ARRAY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY ARRAY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SNP MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SNP MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY OBSTETRICS CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY OBSTETRICS CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CONTRACT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CONTRACT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CLINIC-BASED LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CLINIC-BASED LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DRIED BLOOD SPOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MATERNAL PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MATERNAL PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 185. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2018-2024 (USD MILLION)
TABLE 188. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2025-2030 (USD MILLION)
TABLE 189. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2018-2024 (USD MILLION)
TABLE 190. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2025-2030 (USD MILLION)
TABLE 191. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2018-2024 (USD MILLION)
TABLE 192. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2025-2030 (USD MILLION)
TABLE 193. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 196. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 197. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 198. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 199. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 200. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 201. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2024 (USD MILLION)
TABLE 206. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2025-2030 (USD MILLION)
TABLE 207. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 208. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 209. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 210. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 211. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2018-2024 (USD MILLION)
TABLE 212. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2025-2030 (USD MILLION)
TABLE 213. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2018-2024 (USD MILLION)
TABLE 214. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2025-2030 (USD MILLION)
TABLE 215. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. CANADA NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2018-2024 (USD MILLION)
TABLE 220. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2025-2030 (USD MILLION)
TABLE 221. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2018-2024 (USD MILLION)
TABLE 222. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2025-2030 (USD MILLION)
TABLE 223. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2018-2024 (USD MILLION)
TABLE 224. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2025-2030 (USD MILLION)
TABLE 225. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 228. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 229. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 230. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 231. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 232. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 233. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2024 (USD MILLION)
TABLE 238. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2025-2030 (USD MILLION)
TABLE 239. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 240. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY HEALTHCARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 241. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 242. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 243. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2018-2024 (USD MILLION)
TABLE 244. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY CENTRALIZED, 2025-2030 (USD MILLION)
TABLE 245. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2018-2024 (USD MILLION)
TABLE 246. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DECENTRALIZED, 2025-2030 (USD MILLION)
TABLE 247. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICRODELETION SYNDROME, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY SEX CHROMOSOME ABNORMALITY, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TRISOMY DETECTION, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIGITAL PCR, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY MICROARRAY, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL NON-INVASIVE PRENATAL DNA TESTING SERVICE MARKET SIZE, BY DIRECT-TO-CONSUMER, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL NO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Non-Invasive Prenatal DNA Testing Service market report include:
  • Natera, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • BGI Genomics Co., Ltd.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Myriad Genetics, Inc.
  • Invitae Corporation
  • PerkinElmer, Inc.
  • Progenity, Inc.

Related Topics

Related Reports

Non-invasive Prenatal Testing Market by Component (Consumables & Reagents, Instruments), Test Method (Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection), Gestation Period, Application, End-User - Global Forecast 2025-2030 - Product Image

Non-invasive Prenatal Testing Market by Component (Consumables & Reagents, Instruments), Test Method (Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Ultrasound Detection), Gestation Period, Application, End-User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Australia Non-Invasive Prenatal Testing (NIPT) Market: Focus on Technology, Method, Application, and End User - Forecast, 2024-2033 - Product Image

Australia Non-Invasive Prenatal Testing (NIPT) Market: Focus on Technology, Method, Application, and End User - Forecast, 2024-2033

  • Report
  • 70 Pages
  • Australia
From
Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report - Product Image

Non-Invasive Prenatal Testing (NIPT) - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
U.S. Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Risk, By Method, By Technology, By Product, By Application (Trisomy, Microdeletion Syndrome), By End-use, And Segment Forecasts, 2023 - 2030 - Product Image

U.S. Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Risk, By Method, By Technology, By Product, By Application (Trisomy, Microdeletion Syndrome), By End-use, And Segment Forecasts, 2023 - 2030

  • Report
  • 117 Pages
  • United States
From
Australia Non-Invasive Prenatal Testing Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

Australia Non-Invasive Prenatal Testing Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 90 Pages
  • Australia
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.